Description

(6R,7R)-3-(Carbamoyloxymethyl)-7α-[[2-(2-Furyl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid Sodium Salt is a high-purity pharmaceutical intermediate, specifically a sodium salt derivative of a cephalosporin nucleus. This compound is of critical importance for its role as a key building block in the synthesis of advanced third-generation cephalosporin antibiotics. It is primarily needed by manufacturers in the pharmaceutical and fine chemical industries engaged in the production of active pharmaceutical ingredients (APIs) for broad-spectrum antibacterial medications.

Application

• Pharmaceutical API Synthesis: As a crucial intermediate in the manufacturing of third-generation cephalosporin antibiotics like cefuroxime axetil.
• Antibacterial Drug Development: Serves as a key precursor in R&D for novel β-lactam antibiotics with enhanced stability and efficacy.
• Fine Chemical Production: Used in custom synthesis and contract manufacturing for specialized pharmaceutical compounds.
• Veterinary Medicine: Potential application in the synthesis of antibacterial agents for veterinary use.
• Reference Standard: Can be utilized as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical labs.

Basic Information

Item	Details
Product Name	(6R,7R)-3-(Carbamoyloxymethyl)-7α-[[2-(2-Furyl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid Sodium Salt
CAS No.	90013-55-1
Molecular Formula	C18H17N4NaO8S
Molecular Weight	472.40 g/mol
Synonyms	Cefuroxime Sodium; Cefuroxime Sodium Salt; (6R,7R)-3-[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt; Sodium (6R,7R)-3-[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefuroxime Acid Sodium Salt; 7-[2-(2-Furyl)-2-(methoxyimino)acetamido]-3-[(aminocarbonyl)oxy]methyl]-3-cephem-4-carboxylic Acid Sodium Salt; Zinacef Sodium (related to brand); CXM-Na
EINECS	Contact for details

Quality Control

Our (6R,7R)-3-(Carbamoyloxymethyl)-7α-[[2-(2-Furyl)-2-Methoxyiminoacetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid Sodium Salt is manufactured under strict quality systems. Products undergo rigorous analytical testing, including HPLC, NMR, and IR spectroscopy, to ensure high purity and compliance with pharmaceutical intermediate standards. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each batch to support your quality and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which can affect stability and purity. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%; Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines
pH (10% solution)	6.0 - 8.0

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.